Located at the heart of 900 acres commonly known as the South Texas Medical Center, UT Health San Antonio is the premier academic health institution of the seventh-largest city in the country. The interdisciplinary basic and clinical research across the institution's five schools (Medicine, Dentistry, Nursing, Health Professions, and Graduate) placed San Antonio among the top 3 Texas cities for funding from the National Institutes of Health in FY20.
School of Dentistry's rank among academic institutions receiving NIH funding
Rank among departments in the Nation for:
Rank among departments in the state of Texas for:
start-up companies launched (FY20)
in revenue generated from licensing of intellectual property (FY20)
human studies annually, targeting prevalent disease and disorders
postdoctoral trainees with the Office of Postdoctoral Affairs
industry clinical trial revenue (FY20)
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is among the top 50 on the Nature Index in the following categories, based on the articles published in the highest quality and most selective impact journals across the natural sciences.
Barshop Institute is the only aging-intensive research institute in the country to have the following four designations: two NIA-funded centers (Nathan Shock and Claude D. Pepper), a testing site of the NIA-sponsored Interventions Testing Program, and a U.S. Department of Veterans Affairs Geriatric Research, Education and Clinical Center.
Mays Cancer Center is the only NCI-designated cancer center in South Texas and now affiliated with the sister institution, UT MD Anderson Cancer Center in Houston. This affiliation fosters collaborations to advance breakthrough cancer research and streamlines protocols for multi-site clinical trials. In 2017, the center secured over $40 million in extramural grants, and more than 1,300 patients had the opportunity to participate in clinical trials.
The Institute for the Integration of Medicine & Science (IIMS) mission is to integrate clinical and translational research and career development across the university. Through a $5 million-dollar annual NIH Clinical and Translational Science Award (CTSA), the institute supports early-career investigators. In fiscal year 17 early-career investigator, Bianca Cerqueira (’16 Ph.D. Bioengineering), co-founded Novothelium, a startup focused on breast reconstruction.